Tower Research Capital »

Aligos Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $16k 47k 0.35
2024-03-31 $7.9k 8.0k 0.98
2023-03-31 $0 92 0.00
2022-09-30 $9.0k 8.1k 1.12
2022-06-30 $22k 19k 1.20
2022-03-31 $11k 4.9k 2.24
2021-12-31 $23k 2.0k 11.78
2021-09-30 $14k 873 16.04
2021-06-30 $31k 1.5k 21.05
2021-03-31 $18k 799 22.53
2020-12-31 $14k 499 28.06